Showing results (171-180 of 208) with videos related to

Sort By:
Pageof 21
Presse Medicale (Paris, France : 1983)|April 23, 1983
[Acquired immunodeficiency syndrome in 4 homosexuals]W Rozenbaum, D Klatzmann, C Mayaud, et al.
Radiology|September 1, 1986
Primary lung cancer staging: prospective comparative study of MR imaging with CTD Musset, P Grenier, M F Carette, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 17, 2004
Upregulation of bronchioloalveolar carcinoma-derived C-X-C chemokines by tumor infiltrating inflammatory cellsM Wislez, C Philippe, M Antoine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trialA Depierre, C Chastang, E Quoix, et al.
International Journal of Cancer|March 17, 2000
Prognostic significance of serum p53 antibodies in patients with limited-stage small cell lung cancerG Zalcman, J Trédaniel, B Schlichtholz, et al.
Seminars in Oncology|June 1, 1994
An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancerA Depierre, B Milleron, B Lebeau, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2000
A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancerJ Bennouna, A Monnier, A Rivière, et al.
The American Journal of Pathology|October 5, 2001
Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinomaM Wislez, J Fleury-Feith, N Rabbe, et al.
HIV Medicine|November 16, 2019
Potential lung cancer screening outcomes using different age and smoking thresholds in the ANRS-CO4 French Hospital Database on HIV cohortA Makinson, L Tron, S Grabar, et al.
Anticancer Research|January 1, 1994
Small cell lung cancer: patients surviving longer than thirty months. Groupe d'oncologie de langue françaiseD Moro, P Jacoulet, E Quoix, et al.
Pageof 21